Associate Professor Anita Dunbier
Position | Associate Professor |
---|---|
Department | Department of Biochemistry |
Qualifications | BSc(Hons) PhD |
Research summary | Molecular oncology |
Research
Research in our laboratory focuses on molecular aspects of cancer with particular emphasis on understanding the genotypic and phenotypic determinants of resistance to endocrine therapy in breast cancer.
Current projects
Investigation of genes involved in breast cancer susceptibility and response to therapy
Breast cancer is the most common malignancy in women, accounting for more than 400,000 deaths per year worldwide. Over three quarters of women diagnosed with breast cancer receive anti-oestrogen therapy. We aim to investigate the role of three newly identified genes in breast cancer. We have found that these genes are turned on in breast cancer at the same time as the oestrogen receptor. They also appear to be involved in the way breast cancers respond to treatment and may contribute to genetic susceptibility to breast cancer. We aim to determine why these genes are turned on together and how they then influence the rate at which cancer cells grow. We will also investigate how these genes influence a woman's risk of breast cancer and the way in which she will respond to treatment. Understanding the role of these genes will help to ensure patients receive the most appropriate treatment and to develop more effective therapies.
How do immune cells help breast cancers to evade therapy?
The majority of breast cancers require the hormone oestrogen to grow. Drugs that act by preventing the production of oestrogen are the most effective treatment currently available for this type of cancer. However, these drugs do not work well for all patients. Our previous research suggests that attracting immune cells to the cancer site may cause the cancer to keep growing during therapy. This project aims to identify which immune cells are recruited to breast cancer cells during treatment and how the cancer cells signal to recruit them to the tumour. This research will help us to identify how breast cancers can evade therapy and to identify potential new drugs which could be used in combination with hormonal therapy to improve breast cancer treatments in the future.
Positions available
Enquires about projects from prospective graduate students and postdoctoral fellows are welcome.
Suitably qualified students, from all countries, are eligible to apply for a University of Otago PhD scholarship (continually assessed) which covers tuition fees and provides a generous emolument for living expenses. If you are interested in this possibility please also make contact with me early on.
Awards
- Anita Dunbier
2014, University of Otago Early Career Award for Distinction in Research - Anita Dunbier
2013, OSMS Emerging Researcher Award
For outstanding research achievement where the awardee has held a PhD for between five and ten years and an appointment at Otago for at least two years.
Publications
Hazlett, J., Niemi, V., Aiderus, A., Powell, K., Wise, L., Kemp, R., & Dunbier, A. K. (2021). Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer. Breast Cancer Research, 23, 95. doi: 10.1186/s13058-021-01472-1
Wiggins, G. A. R., Black, M. A., Dunbier, A., Morley-Bunker, A. E., kConFab Investigators, Pearson, J. F., & Walker, L. C. (2021). Increased gene expression variability in BRCA1-associated and basal-like breast tumours. Breast Cancer Research & Treatment, 189, 363-375. doi: 10.1007/s10549-021-06328-y
McMillan, H. D., Keeshan, K., Dunbier, A. K., & Mace, P. D. (2021). Structure vs. function of TRIB1: Myeloid neoplasms and beyond. Cancer, 13, 3060. doi: 10.3390/cancers13123060
Wiggins, G. A. R., Black, M. A., Dunbier, A., Merriman, T. R., Pearson, J. F., & Walker, L. C. (2021). Variable expression quantitative trait loci analysis of breast cancer risk variants. Scientific Reports, 11(1), 7192. doi: 10.1038/s41598-021-86690-5
Jamieson, S. A., Ruan, Z., Burgess, A. E., Curry, J. R., McMillan, H. D., Brewster, J. L., Dunbier, A. K., … Mace, P. D. (2018). Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1. Science Signaling, 11(549), eaau0597. doi: 10.1126/scisignal.aau0597
Dunbier, A. K., & Guilford, P. J. (2002). Gastric cancer: Inherited predisposition. In J. R. Bertino (Ed.), Encyclopedia of cancer. (2nd ed.) (pp. 253-258). Academic Press. [Encyclopaedia/Dictionary Entry].
Chapter in Book - Research
Dunbier, A. K., & Guilford, P. J. (2002). Gastric cancer: Inherited predisposition. In S. R. Hamilton & L. A. Aaltonen (Eds.), Encyclopedia of Cancer, Volume 2. (2nd ed.) (pp. 253-258). USA: Elsevier Science.
Chapter in Book - Research
Hazlett, J., Niemi, V., Aiderus, A., Powell, K., Wise, L., Kemp, R., & Dunbier, A. K. (2021). Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer. Breast Cancer Research, 23, 95. doi: 10.1186/s13058-021-01472-1
Journal - Research Article
Wiggins, G. A. R., Black, M. A., Dunbier, A., Merriman, T. R., Pearson, J. F., & Walker, L. C. (2021). Variable expression quantitative trait loci analysis of breast cancer risk variants. Scientific Reports, 11(1), 7192. doi: 10.1038/s41598-021-86690-5
Journal - Research Article
Wiggins, G. A. R., Black, M. A., Dunbier, A., Morley-Bunker, A. E., kConFab Investigators, Pearson, J. F., & Walker, L. C. (2021). Increased gene expression variability in BRCA1-associated and basal-like breast tumours. Breast Cancer Research & Treatment, 189, 363-375. doi: 10.1007/s10549-021-06328-y
Journal - Research Article
Aiderus, A., Black, M. A., & Dunbier, A. K. (2018). Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers. BMC Cancer, 18, 805. doi: 10.1186/s12885-018-4626-9
Journal - Research Article
Jamieson, S. A., Ruan, Z., Burgess, A. E., Curry, J. R., McMillan, H. D., Brewster, J. L., Dunbier, A. K., … Mace, P. D. (2018). Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1. Science Signaling, 11(549), eaau0597. doi: 10.1126/scisignal.aau0597
Journal - Research Article
Prat, A., Lluch, A., Turnbull, A. K., Dunbier, A. K., Calvo, L., Albanell, J., … Alba, E. (2017). A PAM50-based chemoendocrine score for hormone receptor-positive breast cancer with an intermediate risk of relapse. Clinical Cancer Research, 23(12). doi: 10.1158/1078-0432.ccr-16-2092
Journal - Research Article
López-Knowles, E., Wilkerson, P. M., Ribas, R., Anderson, H., Mackay, A., Ghazoui, Z., … Dunbier, A. K., … Dowsett, M. (2015). Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer. Breast Cancer Research, 17, 35. doi: 10.1186/s13058-015-0532-0
Journal - Research Article
Turnbull, A. K., Arthur, L. M., Renshaw, L., Larionov, A. A., Kay, C., Dunbier, A. K., … Dixon, J. M. (2015). Accurate prediction and validation of response to endocrine therapy in breast cancer. Journal of Clinical Oncology, 33(20), 2270-2278. doi: 10.1200/jco.2014.57.8963
Journal - Research Article
Gao, Q., Patani, N., Dunbier, A. K., Ghazoui, Z., Zvelebil, M., Martin, L.-A., & Dowsett, M. (2014). Effect of aromatase inhibition on functional gene modules in estrogen receptor–positive breast cancer and their relationship with antiproliferative response. Clinical Cancer Research, 20(9), 2485-2494. doi: 10.1158/1078-0432.CCR-13-2602
Journal - Research Article
Patani, N., Dunbier, A. K., Anderson, H., Ghazoui, Z., Ribas, R., Anderson, E., … Dowsett, M. (2014). Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer. Clinical Cancer Research, 20(15), 3962-3973. doi: 10.1158/1078-0432.ccr-13-1378
Journal - Research Article
Ribas, R., Ghazoui, Z., Gao, Q., Pancholi, S., Rani, A., Dunbier, A., … Martin, L.-A. (2014). Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers. Breast Cancer Research, 16, 447. doi: 10.1186/s13058-014-0447-1
Journal - Research Article
Dowsett, M., Sestak, I., Lopez-Knowles, E., Sidhu, K., Dunbier, A. K., Cowens, J. W., … Cuzick, J. (2013). Comparison of PAM50 risk of recurrence score with Oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. Journal of Clinical Oncology, 31(22), 2783-2790. doi: 10.1200/jco.2012.46.1558
Journal - Research Article
Dunbier, A. K., Ghazoui, Z., Anderson, H., Salter, J., Nerurkar, A., Osin, P., … Dowsett, M. (2013). Molecular profiling of aromatase inhibitor-treated post-menopausal breast tumors identifies immune-related correlates of resistance. Clinical Cancer Research, 19(10), 2775-2786. doi: 10.1158/1078-0432.ccr-12-1000
Journal - Research Article
Sgroi, D. C., Sestak, I., Cuzick, J., Zhang, Y., Schnabel, C. A., Schroeder, B., … Dunbier, A., … Dowsett, M. (2013). Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: A prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population. Lancet Oncology, 14, 1067-1076. doi: 10.1016/S1470-2045(13)70387-5
Journal - Research Article
Weigel, M. T., Ghazoui, Z., Dunbier, A. K., Pancholi, S., Dowsett, M., & Martin, L.-A. (2012). Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer. Breast Cancer Research, 14(3), R78. doi: 10.1186/bcr3191
Journal - Research Article
Dowsett, M., Smith, I., Robertson, J., Robison, L., Pinhel, I., Johnson, L., … Dunbier, A., … Bliss, J. (2011). Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer. Journal of the National Cancer Institute Monographs, 43, 120-123. doi: 10.1093/jncimonographs/lgr034
Journal - Research Article
Dunbier, A. K., Anderson, H., Ghazoui, Z., Lopez-Knowles, E., Pancholi, S., Ribas, R., … Dowsett, M. (2011). ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1. PLoS Genetics, 7(4), e1001382. doi: 10.1371/journal.pgen.1001382
Journal - Research Article
Dunbier, A. K., Anderson, H., Ghazoui, Z., Salter, J., Parker, J. S., Perou, C. M., … Dowsett, M. (2011). Association between breast cancer subtypes and response to neoadjuvant anastrozole. Steroids, 76(8), 736-740. doi: 10.1016/j.steroids.2011.02.025
Journal - Research Article
Dunbier, A. K., Martin, L.-A., & Dowsett, M. (2011). New and translational perspectives of oestrogen deprivation in breast cancer. Molecular & Cellular Endocrinology, 340(2), 137-141. doi: 10.1016/j.mce.2010.12.034
Journal - Research Article
Ghazoui, Z., Buffa, F. M., Dunbier, A. K., Anderson, H., Dexter, T., Detre, S., … Dowsett, M. (2011). Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancer. Clinical Cancer Research, 17(9), 3005-3012. doi: 10.1158/1078-0432.ccr-10-1704
Journal - Research Article
Lønning, P. E., Haynes, B. P., Straume, A. H., Dunbier, A., Helle, H., Knappskog, S., & Dowsett, M. (2011). Recent data on intratumor estrogens in breast cancer. Steroids, 76(8), 786-791. doi: 10.1016/j.steroids.2011.02.040
Journal - Research Article
Lønning, P. E., Haynes, B. P., Straume, A. H., Dunbier, A., Helle, H., Knappskog, S., & Dowsett, M. (2011). Exploring breast cancer estrogen disposition: The basis for endocrine manipulation. Clinical Cancer Research, 17(15), 4948-4958. doi: 10.1158/1078-0432.ccr-11-0043
Journal - Research Article
Martin, L.-A., Ghazoui, Z., Weigel, M. T., Pancholi, S., Dunbier, A., Johnston, S., & Dowsett, M. (2011). An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibition. Steroids, 76, 772-776. doi: 10.1016/j.steroids.2011.02.035
Journal - Research Article
Miller, T. W., Balko, J. M., Fox, E. M., Ghazoui, Z., Dunbier, A., Anderson, H., … Arteaga, C. L. (2011). ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. Cancer Discovery, 1, 338-351. doi: 10.1158/2159-8290.CD-11-0101
Journal - Research Article
Miller, T. W., Balko, J. M., Ghazoui, Z., Dunbier, A., Anderson, H., Dowsett, M., … Arteaga, C. L. (2011). A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance. Clinical Cancer Research, 17(7), 2024-2034. doi: 10.1158/1078-0432.ccr-10-2567
Journal - Research Article
Dowsett, M., Cuzick, J., Wale, C., Forbes, J., Mallon, E. A., Salter, J., … Dunbier, A., … Shak, S. (2010). Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: A TransATAC study. Journal of Clinical Oncology, 28(11), 1829-1834. doi: 10.1200/JCO.2009.24.4798
Journal - Research Article
Dunbier, A. K., Anderson, H., Ghazoui, Z., Folkerd, E. J., A’Hern, R., Crowder, R. J., … Dowsett, M. (2010). Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. Journal of Clinical Oncology, 28(7), 1161-1167. doi: 10.1200/JCO.2009.23.9616
Journal - Research Article
Dowsett, M., & Dunbier, A. K. (2008). Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clinical Cancer Research, 14(24), 8019-8026. doi: 10.1158/1078-0432.ccr-08-0974
Journal - Research Article
Humar, B., McNoe, L., Dunbier, A., Heathcott, R., Braithwaite, A. W., & Reeve, A. E. (2008). Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition. Biologics, 2(2), 329-337.
Journal - Research Article
Kendall, A., Anderson, H., Dunbier, A. K., Mackay, A., Dexter, T., Urruticoechea, A., … Dowsett, M. (2008). Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo. Cancer Epidemiology, Biomarkers & Prevention, 17(4), 855-863. doi: 10.1158/1055-9965.epi-07-2718
Journal - Research Article
Nasri, S., More, H., Graziano, F., Ruzzo, A., Wilson, E., Dunbier, A., McKinney, C., Merriman, T., Guilford, P., … Humar, B. (2008). A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population. BMC Cancer, 8, 138. doi: 10.1186/1471-2407-8-138
Journal - Research Article
Humar, B., Fukuzawa, R., Blair, V., Dunbier, A., More, H., Charlton, A., … Reeve, A. E., … Guilford, P. (2007). Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Research, 67(6), 2480-2489. doi: 10.1158/0008-5472.CAN-06-3021
Journal - Research Article
da Silva Tatley, F. M., Aldwell, F., Dunbier, A. K., & Guilford, P. J. (2003). N-terminal E-cadherin peptides act as decoy receptors for Listeria monocytogenes. Infection & Immunity, 71(3), 1580-1583.
Journal - Research Article
Dunbier, A. K., & Guilford, P. J. (2001). Hereditary diffuse gastric cancer. Advances in Cancer Research, 83, 55-65.
Journal - Research Article
Grady, W. M., Willis, J., Guilford, P. J., Dunbier, A. K., Toro, T. T., Lynch, H., … Markowitz, S. D. (2000). Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nature Genetics, 26, 16-17.
Journal - Research Article
McMillan, H. D., Keeshan, K., Dunbier, A. K., & Mace, P. D. (2021). Structure vs. function of TRIB1: Myeloid neoplasms and beyond. Cancer, 13, 3060. doi: 10.3390/cancers13123060
Journal - Research Other
Dunbier, A. K., Hong, Y., Masri, S., Brown, K. A., Sabnis, G. J., & Palomares, M. R. (2010). Progress in aromatase research and identification of key future directions. Journal of Steroid Biochemistry & Molecular Biology, 118(4-5), 311-315. doi: 10.1016/j.jsbmb.2009.09.005
Journal - Research Other